Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Codexis stock
Learn how to easily invest in Codexis stock.
Codexis Inc is a biotechnology business based in the US. Codexis shares (CDXS) are listed on the NASDAQ and all prices are listed in US Dollars. Codexis employs 261 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Codexis
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CDXS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Codexis stock price (NASDAQ: CDXS)Use our graph to track the performance of CDXS stocks over time.
Codexis shares at a glance
|Latest market close||$10.88|
|52-week range||$8.11 - $42.01|
|50-day moving average||$10.74|
|200-day moving average||$22.25|
|Wall St. target price||$33.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.32|
Buy Codexis shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Codexis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Codexis price performance over time
|1 week (2022-06-29)||-2.16%|
|1 month (2022-06-06)||13.45%|
|3 months (2022-04-05)||-48.36%|
|6 months (2022-01-06)||-59.33%|
|1 year (2021-07-06)||-50.92%|
|2 years (2020-07-06)||-12.19%|
|3 years (2019-07-05)||18.59|
|5 years (2017-07-05)||105.28%|
|Revenue TTM||$122.1 million|
|Gross profit TTM||$26.6 million|
|Return on assets TTM||-6.13%|
|Return on equity TTM||-12.76%|
|Market capitalisation||$710.5 million|
TTM: trailing 12 months
Codexis share dividends
We're not expecting Codexis to pay a dividend over the next 12 months.
Codexis share price volatility
Over the last 12 months, Codexis's shares have ranged in value from as little as $8.11 up to $42.01. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Codexis's is 1.9673. This would suggest that Codexis's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe.
Codexis in the news
Codexis (CDXS) Surges 9.7%: Is This an Indication of Further Gains?
The 26% return this week takes Codexis' (NASDAQ:CDXS) shareholders five-year gains to 110%
Codexis Announces the Publication of Research Demonstrating Proof of Concept for Chemoenzymatic Site-Selective Bioconjugation of Native Peptides
Frequently asked questionsWhat percentage of Codexis is owned by insiders or institutions?
Currently 2.648% of Codexis shares are held by insiders and 99.078% by institutions. How many people work for Codexis?
Latest data suggests 261 work at Codexis. When does the fiscal year end for Codexis?
Codexis's fiscal year ends in December. Where is Codexis based?
Codexis's address is: 200 Penobscot Drive, Redwood City, CA, United States, 94063 What is Codexis's ISIN number?
Codexis's international securities identification number is: US1920051067 What is Codexis's CUSIP number?
Codexis's Committee on Uniform Securities Identification Procedures number is: 192005106
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert